
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Trabectedin
Therapeutic Area : Oncology
Study Phase : Approved FDF
Recipient : PharmaMar
Deal Size : Undisclosed
Deal Type : Licensing Agreement
Details : Under the agreement, Taiwan Toyo will distribute the new anti-cancer drug Yondelis (trabectedin), a newly synthesized anti-tumor drug derived from the sea squirt Ecteinascidia turbinata, in Taiwan, Hong Kong and Macau.
Product Name : Yondelis
Product Type : Miscellaneous
Upfront Cash : Undisclosed
June 09, 2020
Lead Product(s) : Trabectedin
Therapeutic Area : Oncology
Highest Development Status : Approved FDF
Recipient : PharmaMar
Deal Size : Undisclosed
Deal Type : Licensing Agreement
